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Abstract
Postoperative delirium is a common and harrowing complication in older
surgical patients. Those with cognitive impairment or dementia are at
especially high risk for developing postoperative delirium; ominously, it is
hypothesized that delirium can accelerate cognitive decline and the onset
of dementia, or worsen the severity of dementia. Awareness of delirium has
grown in recent years as various medical societies have launched initiatives
to prevent postoperative delirium and alleviate its impact. Unfortunately,
delirium pathophysiology is not well understood and this likely contributes
to the current state of low-quality evidence that informs perioperative
guidelines. Along these lines, recent prevention trials involving ketamine
and dexmedetomidine have demonstrated inconsistent findings.
Non-pharmacologic multicomponent initiatives, such as the Hospital Elder
Life Program, have consistently reduced delirium incidence and burden
across various hospital settings. However, a substantial portion of delirium
occurrences are still not prevented, and effective prevention and
management strategies are needed to complement such multicomponent
non-pharmacologic therapies. In this narrative review, we examine the
current understanding of delirium neurobiology and summarize the present
state of prevention and management efforts.
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Introduction
Delirium is an enigmatic clinical syndrome characterized by an 
acute and typically reversible failure of our brain’s basic cogni-
tive and attentional functions. Delirium can be associated with 
alterations in level of consciousness and is characterized by a 
fluctuating course. Those with delirium are often either agitated 
(hyperactive type) or lethargic (hypoactive type) or alternate 
between these motor subtypes (mixed type). Delirium occurs com-
monly in older adults, especially when there is pre-existing neu-
rocognitive impairment and also following an insult such as an 
infection or a trauma. With many vulnerable older adults requir-
ing surgery, postoperative delirium specifically is a growing pub-
lic health concern, occurring with an incidence of 20 to 50% in 
those older than 60 after major surgery1,2. When patients become 
delirious, this is often the most distressing element of the periop-
erative experience, both for them and for their family members. 
Furthermore, postoperative delirium is associated with increased 
mortality3, cognitive and functional decline4–6, increased hos-
pital length of stay7, and substantial annual health-care costs8. 
Despite the grave nature of delirium and its associated burdens, 
foundational problems have tempered the pace of clinical and 
scientific progress. Most fundamentally, the pathophysiology of 
delirium phenomenology9 remains incompletely understood. 
Although it is appropriate that diagnosis of a clinical syndrome 
is informed by bedside observations, this ideally should be 
accompanied by a clear understanding of the underlying patho-
physiology. Additionally, delirium screening tools (for example, 
the Confusion Assessment Method for the Intensive Care Unit 
and the Delirium Observation Screening scale) used in routine 
clinical practice demonstrate low sensitivity (about 30%) com-
pared with expert-based delirium identification (that is, psychia-
trist, geriatrician, or neurologist performing chart reviews and 
completing similar delirium screening assessments)10. Further-
more, diagnostic disagreement may be common among such 
experts10. In fact, diagnostic discrepancy even occurs with 
different Diagnostic and Statistical Manual of Mental Disor-
ders (DSM) editions. In an examination of a pooled dataset of 
prospective studies investigating delirium, strict DSM-5 criteria 
identified only 30% of delirium cases diagnosed via DSM-IV 
criteria11. Although guidelines have been published for the pre-
vention of postoperative delirium12–14, they are often supported by 
low-quality evidence12,15,16. Furthermore, implementation efforts 
may be limited by the required administrative support, resources, 
and health-care staff education17,18. Thus, with an incomplete 
pathophysiologic understanding, a deficient diagnostic tool-
box, and limited guideline evidence and implementation capac-
ity, prevention and management of delirium are inherently 
challenging.
Multiple steps can be taken to improve clinical understanding 
and management of delirium. First, elucidating the neurobio-
logic mechanisms of delirium will advance understanding of 
the syndrome. These efforts could help produce targeted thera-
peutic strategies that address and alleviate intrinsic pathophysi-
ologic perturbations. Second, improvement in current guideline 
implementation and adherence may still reduce delirium inci-
dence and improve related outcomes19. In this narrative review, we 
examine the current understanding of delirium pathophysiology 
and summarize what is known regarding prevention and man-
agement efforts. Future directions are briefly discussed with a 
focus on improving diagnostic and management strategies.
Delirium pathogenesis: current understanding
Delirium classification and diagnosis currently rely on pheno-
typic descriptions of altered brain states (for example, inatten-
tion and disorganized thinking) rather than a neurobiologically 
informed framework. By comparison, perioperative cardiovas-
cular perturbations (for example, wall motion abnormalities 
and tamponade) can be diagnosed at the bedside with currently 
available technology and diagnostic acumen. No analogous, 
standard neurophysiologic evaluation process exists for diagnos-
ing or evaluating the severity of altered postoperative brain states. 
This deficit in pathophysiologic understanding likely contributes 
to the current state of ineffective prevention and management. 
This has been reinforced by recent large pharmacologic trials 
that have failed to demonstrate reductions in postoperative delir-
ium risk despite promising preliminary data2,20. Additionally, a 
systematic review in 2016 demonstrated that then-current phar-
macologic treatment strategies were ineffective for reducing 
delirium duration or severity21. Our hope is that such informative 
trials will galvanize investigative efforts to better understand 
the pathophysiology of delirium and related brain states22.
The pathophysiologic framework of delirium has evolved over 
recent years with advances in neurocognitive research. From a 
systems neuroscience perspective, neurotransmitter imbalances— 
particularly involving dopamine and acetylcholine—have been 
implicated in delirium pathogenesis23. Sleep disruption and 
polypharmacy may contribute to such neurotransmitter altera-
tions (reviewed in Watson et al.24). Neuroinflammation may also 
play a role as specific neuroinflammatory protein signatures 
track with postoperative delirium25,26. The net effect of these per-
turbations may manifest as network-level alterations in infor-
mation processing. In fact, using 21-channel electroencepha-
lographic (EEG) data, van Dellen et al. demonstrated reduced 
functional connectivity, altered directionality of information flow, 
and network topology changes during delirious episodes in car-
diac surgery patients27. This group published subsequent data 
comparing EEG measures of hypoactive delirium with non-
delirious controls and those recovering from anesthesia in the 
immediate postoperative setting28. Hypoactive delirium was 
distinguished from these other states by network topology fea-
tures, as measures of network integration in the alpha band were 
reduced. Network science may help shape our understanding 
of brain state transitions perioperatively (reviewed in Lee and 
Mashour29) and this could apply to delirium as well as to other 
altered brain states. Shafi et al. have proposed a model by which 
transcranial magnetic stimulation could be used to assess con-
nectivity and neuroplasticity in real time22, hypothesizing that 
reduced baseline connectivity and plasticity contribute to delir-
ium risk. This neurophysiologic line of investigation ultimately 
may produce bedside tools for objective risk stratification 
and diagnosis of altered brain states, based on the underlying 
neurobiology. Preliminary work, based on frontal-parietal oscilla-
tory patterns, has already shown promise in identifying delirium 
with high reliability against reference DSM-IV–based criteria30.
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Recent prevention strategies
Despite the knowledge gaps in delirium pathogenesis, delirium 
may still be preventable with targeted, multicomponent interven-
tions31. Given the harmful nature of delirium and the apparent 
failure of currently used drugs (for example, haloperidol) for 
prophylaxis and treatment21, prevention efforts have expanded 
through recent investigation of novel pharmacologic and non- 
pharmacologic strategies.
Pharmacologic
Ketamine has been found to reduce postoperative inflammation32, 
improve perioperative pain outcomes33, and reduce excitotox-
icity in laboratory models34. Results from a small trial also 
demonstrated decreased occurrence of delirium and decreased 
incidence of delayed neurocognitive recovery in cardiac sur-
gery patients who received intraoperative ketamine compared 
with placebo35,36. With this background and rationale, an interna-
tional team of investigators conducted the PODCAST (Preven-
tion of Delirium and Complications Associated with Surgical 
Treatments) trial, hypothesizing that a sub-anesthetic, intraop-
erative dose of ketamine would reduce postoperative delirium37. 
In this trial, ketamine had no statistically significant effect on 
delirium incidence (ketamine groups: 19.45%, placebo group: 
19.82%, absolute difference 0.36%, 95% confidence inter-
val [CI] −6.07 to 7.38; P = 0.92), delirium severity, or delirium 
recurrence2. Instead, dose-dependent increases were reported for 
postoperative hallucinations (18% in the placebo group, 20% in 
the 0.5 mg/kg ketamine group, and 28% in the 1.0 mg/kg keta-
mine group; P = 0.01) and nightmares (8% in the placebo group, 
12% in the 0.5 mg/kg ketamine group, and 15% in the 1.0 mg/kg 
ketamine group; P = 0.03). These findings align with previously 
known psychoactive side effects of ketamine33,38,39. Thus, intra-
operative ketamine probably does not prevent delirium; rather, 
ketamine may increase the risk of adverse perioperative 
psychoactive experiences.
Dexmedetomidine has also been tested in large randomized tri-
als in relation to postoperative delirium. A 2014 meta-analysis 
examined dexmedetomidine use across 14 trials involving cardiac 
surgery and intensive care unit (ICU) patients40. In these trials, 
dexmedetomidine was investigated as a sedation agent, primarily 
for mechanically ventilated patients, compared with gamma- 
aminobutyric acid–based sedative-hypnotics (for example, pro-
pofol and midazolam). In this context, dexmedetomidine use was 
associated with reduction in the composite outcome of delirium, 
agitation, and confusion (relative risk [RR] 0.68, 95% CI 0.49 
to 0.96; P = 0.03). Similar findings were presented in a meta- 
analysis by Duan et al.41. Delirium incidence was significantly 
lower in surgical populations receiving dexmedetomidine (odds 
ratio [OR] 0.35, 95% CI 0.24 to 0.51; I2 = 53%). However, the 
two largest studies in the meta-analysis may provide a nuanced 
perspective. The largest trial was performed by Su et al., who 
conducted a 700-patient, double-blinded, randomized control-
led trial in which dexmedetomidine, administered in the ICU 
until the morning after major non-cardiac surgery, was associated 
with an impressive 13.4% absolute reduction (95% CI 8.1% to 
18.7%) in postoperative delirium incidence42. However, there are 
some concerns regarding the methodology of this trial43. The 
majority of participants (nearly 60%) were consented by proxy 
postoperatively, and participants were not tested for delirium 
at the time of enrollment. Thus, the primary outcome was likely 
present in some patients in both groups prior to the interven-
tion. Furthermore, the biological plausibility remains in question, 
as a robust delirium reduction was achieved with a small, sub- 
sedative dose rate (0.1 μg/kg per hour). Nonetheless, prelimi-
nary data demonstrate that low-dose-rate dexmedetomidine may 
improve perioperative sleep44–46, which has been postulated to 
mitigate delirium risk47. A trial by Deiner et al. demonstrated 
no significant difference in delirium incidence between dexme-
detomidine (12.2%) and placebo (11.4%) groups (RR 1.06, 95% 
CI 0.79 to 1.41; P = 0.77)20. The study design was different, as 
dexmedetomidine was started intraoperatively and continued for 
only 2 hours postoperatively. Nonetheless, the trial was stopped 
early for futility, as dexmedetomidine did not appear to influ-
ence delirium risk or cognitive function 3 to 6 months after 
surgery. Of note, however, relevant confounders (for example, 
anesthetic and analgesic consumption) were not comprehen-
sively reported and this contributed to trial limitations. Overall, 
dexmedetomidine may mitigate delirium risk in mechanically 
ventilated, critically ill patients; however, its prophylactic use in 
the intraoperative and immediate postoperative setting, particu-
larly for non-cardiac surgery patients, remains controversial43,48. 
Large multicenter trials, with preoperative delirium testing, rigor-
ous delirium assessment, and multiple treatment arms (for dose 
comparisons), are warranted to refine the evidence regarding 
the role of dexmedetomidine in preventing or treating delirium.
Apart from ketamine and dexmedetomidine, other drugs have 
shown some promise as prophylactic agents in both cardiac and 
non-cardiac surgery. These include acetaminophen, ramelt-
eon, gabapentin, statins, clonidine, and melatonin49,50. Recently, 
a small, industry-funded, single-center trial demonstrated that 
intravenous acetaminophen every 6 hours for 48 hours after car-
diac surgery was associated with an impressive 18% (95% CI −32 
to −5%; P = 0.01) absolute risk reduction in delirium incidence 
compared with placebo51. However, this result, as noted by 
the investigators51, should be viewed as hypothesis-generating 
only. The biological plausibility of acetaminophen decreasing 
delirium incidence, especially to such a large extent, is question-
able. Therefore, even with this encouraging finding, the probabil-
ity that acetaminophen is effective at preventing delirium should 
still be regarded as low52. A common misunderstanding is that 
P values provide direct information regarding the probability of 
the truth or falsity of hypotheses53. The P value, if inappropri-
ately used for (null) hypothesis testing, substantially overstates 
the evidence against the null hypothesis54. The fragility index 
(which suffers from the same limitations as P values) has been 
proposed to assess the robustness of positive results in clini-
cal trials55. The fragility index55 calculation for this trial51 indi-
cates that if just two patients in the acetaminophen group were 
“converted” to having delirium, the results would lose statisti-
cal significance at an arbitrary P value of less than 0.05. Another 
major constraint of this trial was that the control group received 
placebo56 rather than oral or rectal acetaminophen, which often 
is standard practice after cardiac surgery. In order to adopt a new 
expensive treatment, like intravenous acetaminophen, it would 
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be necessary to show that it was superior to inexpensive alterna-
tives, like the generic oral formulation of the same drug. Given 
these important limitations, the results of this trial should be 
tested for reproducibility in a large, multicenter trial, as the inves-
tigators themselves have recommended51. Atypical antipsychotic 
agents, such as haloperidol and quetiapine, have not shown ben-
efit in preventing or treating delirium57. Similarly, steroids, which 
have non-specific anti-inflammatory properties, have not been 
effective at preventing postoperative delirium58. Pending more 
compelling evidence, no pharmacologic agent currently can be 
recommended for prophylaxis of postoperative delirium49.
Depth of anesthesia
Within the last decade, a growing body of evidence has impli-
cated anesthetic depth as a possible contributor to postoperative 
delirium. The Cognitive Dysfunction after Anesthesia (CODA) 
trial was published in 2013. Of 1000 patients who were planned for 
randomization, 921 older non-cardiac surgery patients (≥60 
years of age) were randomly assigned to bispectral index (BIS)-
guided anesthesia versus routine care59. General anesthesia was 
achieved with ether-derived inhaled agents or with propofol intra-
venous anesthesia. Postoperative delirium, which was assessed 
in 902 patients, was reduced by 8.6% (95% CI 3.4 to 13.7) 
(relative reduction of 35%, 95% CI 16 to 51%) in the BIS-guided 
group, and cognitive dysfunction was also less common in the 
guided group 3 months after surgery. Of note, however, delirium 
was a secondary outcome of the trial, delirium was assessed 
only once daily, information on missing delirium data was not 
reported, delirium assessment training was not discussed, and 
protocol deviations were not reported. The same year, Radtke 
et al. reported findings from the Surgery Depth of Anaesthe-
sia and Cognitive Outcome (SuDoCo) trial, which enrolled 1277 
older non-cardiac surgery patients60. Notably, the investigators 
specified a priori that 1600 patients would be enrolled (ISRCTN 
Register: 36437985), but the study was stopped early because 
of shortage of funds. General anesthesia was either with ether-
derived inhaled agents or with propofol intravenous anesthesia. 
Interestingly, mean BIS values were almost identical (~39) in the 
BIS-guided and blinded groups. Delirium incidence was reported 
for 90.4% (1155 patients) and was significantly reduced in 
the BIS-guided group (16.5% versus 21.4%, absolute reduc-
tion 4.9%, 95% CI 0.3 to 9.4%; P = 0.036)60. However, in the 
BIS-blinded group, clinicians deviated from the study protocol 
and unblinded themselves to BIS values for 141 patients at some 
point during surgery. By conducting the analysis with these patients 
in the BIS-guided group (that is, per-protocol approach), the 
association between BIS monitoring and delirium is not statisti-
cally significant (17.2% versus 21.9%, absolute reduction 4.7%, 
95% CI −0.1 to 9.4%; P = 0.053). Observational data also dem-
onstrate an association between intraoperative EEG suppres-
sion and postoperative delirium risk, even after adjustment for 
relevant confounders61,62. Collectively, these studies suggest that 
deep anesthesia—which is marked by EEG suppression—may 
causally contribute to postoperative delirium. Alternatively, the 
excessive presence of EEG suppression may reflect underly-
ing neurologic vulnerability, indicating a higher inherent risk of 
delirium. The Electroencephalography Guidance of Anesthe-
sia to Alleviate Geriatric Syndromes (ENGAGES) trial 
(ClinicalTrials.gov Identifier: NCT02241655) addressed this ques-
tion by randomly assigning 1232 surgical patients to EEG-guided 
anesthesia—with a focus on avoiding EEG suppression—versus 
usual, EEG-blinded care63,64. Postoperative delirium occurred in 
157 (26.0%) out of 604 patients in the EEG-guided group com-
pared with the 140 (23.0%) out of 609 in the usual care group 
(absolute difference 3.0%, 95% CI −2.0 to 8.0; P = 0.22). The EEG-
guided group had 46% (95% CI 16 to 76%) less EEG suppression 
time and 14% (95% CI 12 to 16%) less volatile anesthetic expo-
sure. The findings suggest that EEG-guided anesthesia probably 
does not reduce postoperative delirium occurrence substantially 
in older surgical patients, even if EEG suppression time dur-
ing surgery is decreased. The trial had specific methodological 
strengths, including structured delirium assessment training, fidel-
ity checks for protocol compliance, and validated chart review 
methods to complement in-person delirium interviews. The 
ENGAGES trial also had several limitations, including the fol-
lowing: (i) single-center design, potentially limiting generaliz-
ability; (ii) lack of objective diagnostic criteria or biomarkers 
for delirium, which is a common consideration for all studies 
focusing on delirium; (iii) the potential for missed delirium occur-
rences given that delirium is a fluctuating disorder and could be 
missed with interval or insufficient assessments; and (iv) the 
potentially limited applicability to general anesthesia based on 
intravenous anesthetic agents. The results from these trials are 
illustrated meta-analytically in Figure 1.
Figure 1. Meta-analysis summarizing four trials in which the intervention group received electroencephalogram-guided anesthesia. 
This analysis was conducted by using OpenMetaAnalyst65 and was based on a binary, random effects, Hartung–Knapp–Sidik–Jonkman 
model66,67. The I2 = 74%, tau2 = 0.08, Q(df = 3) = 13.234, and heterogeneity P value = 0.004. The estimated odds ratio for delirium with 
intervention (electroencephalogram-guided [reduction in] anesthesia) = 0.764 (95% confidence interval 0.549 to 1.061, P = 0.108). BAG-
RECALL, Bispectral Index or Anesthesia Gas to Reduce Explicit Recall; C.I., confidence interval; CODA, Cognitive Dysfunction after 
Anesthesia; ENGAGES, Electroencephalography Guidance of Anesthesia to Alleviate Geriatric Syndromes; SuDoCo-PP, Surgery Depth of 
Anaesthesia and Cognitive Outcome per-protocol.
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Findings from the ENGAGES trial are consistent with those of 
systematic reviews of hip fracture surgery studies that have found 
no association between anesthetic technique (that is, general 
versus neuraxial anesthesia) and postoperative delirium risk68–70. 
Similar findings were demonstrated in the STRIDE (Strategy 
to Reduce the Incidence of Postoperative Delirium in Elderly 
Patients) trial71, which randomly assigned patients undergo-
ing surgery for hip fracture (n = 200) to light versus heavy seda-
tion during spinal anesthesia. Overall, there was no significant 
difference in delirium incidence in the light sedation group 
(34/100, 34%) compared with the heavy sedation group (39/100, 
39%; absolute reduction 5.0%, 95% CI −8.3 to 18.3%; P = 
0.46). Thus, both the ENGAGES trial and data from the hip 
fracture surgery literature do not support current recommenda-
tions to use EEG-guided anesthesia for patients at risk in order to 
prevent postoperative delirium12. This conclusion may be refined 
after the findings of the ENGAGES-Canada trial (ClinicalTri-
als.gov Identifier: NCT02692300) and Balanced Anesthesia 
Trial72 are published.
Behavioral and multicomponent interventions
One of the most consistently effective delirium prevention 
strategies involves a multicomponent intervention that targets 
modifiable risk factors. The Hospital Elder Life Program (HELP), 
founded by Sharon K. Inouye et al., is a multidisciplinary pro-
gram designed to prevent cognitive and functional decline in 
older hospitalized patients, and the focus is on delirium73. HELP 
services include cognitive orientation, social support, sleep pro-
tocol implementation, assistance with nutrition and mobilization, 
and education for health-care staff. HELP has expanded to over 
200 sites worldwide, and positive outcomes have been 
reproduced across several hospital settings and locations. A recent 
meta-analysis involving 14 studies demonstrated significant 
reductions in delirium incidence (OR 0.47, 95% CI 0.37 to 0.59; 
I2 = 28%), risk of falls (OR 0.58, 95% CI 0.35 to 0.95; I2 = 0%), 
and health-care costs ($16,000 USD per person-year)31. Despite 
the paucity of effective delirium prevention strategies, HELP 
stands as a consistent, reproducible intervention for preventing 
delirium in high-risk patients.
Cognitive prehabilitation is also being studied as an approach 
for strengthening cognitive reserve in surgical patients74. So-
called “brain training” efforts have been hypothesized to cur-
tail the risk of postoperative delirium and cognitive impairment. 
Computerized cognitive training exercises have demonstrated 
cognitive benefit in non-surgical patients across a wide vari-
ety of clinical settings75. However, modest gains are generally 
observed in the short term, and training appears to require direct 
supervision, over several hours, and spaced out over multiple 
weeks to avoid cognitive fatigue75,76. In fact, preliminary data 
demonstrate that such training programs are unlikely to be feasi-
ble for many older patients77. Time commitment and preoperative 
anxiety served as barriers to training adherence, and those ran-
domly assigned to training were more likely to withdraw from the 
study. Although larger-scale trials are ongoing (ClinicalTrials.gov 
Identifier: NCT0223060574), cognitive prehabilitation may 
not be feasible for many older patients prior to surgery.
Clinical management
Medical associations such as the UK’s National Institute for 
Health and Care Excellence, the European Society of Anaesthesi-
ology, and the American Geriatrics Society offer evidence-based 
guidelines for postoperative delirium management12,13,78. Ini-
tial steps focus on identifying and treating precipitating etiolo-
gies. In hospitalized patients, iatrogenic causes include infection, 
polypharmacy, fluid and electrolyte disturbances, and organ 
failure (with associated physiologic perturbations). Concurrent 
with treating the underlying medical condition, supportive efforts 
can be implemented to mitigate delirium severity. Non-pharma-
cologic interventions, such as delirium education programs for 
medical staff, have led to reductions in delirium duration, hospi-
tal length of stay, and mortality79. Such programs can also improve 
delirium recognition and disposition and are associated with reduc-
tions in point prevalence80. Pharmacologic interventions for treat-
ing active delirium have been studied for many years, although 
most studies have not found candidate drugs to be effective.
Neufeld et al. recently published a systematic review to examine 
antipsychotic medication treatment for delirium21. The authors 
reviewed 19 studies, which included various typical and atypi-
cal antipsychotics across diverse hospital settings, and found that 
antipsychotics demonstrated no significant effects on delirium 
incidence, duration, or severity, or on hospital length of stay. 
In fact, a subsequent clinical trial by Agar et al. demonstrated 
improved survival, reduced delirium severity scores, and fewer 
extrapyramidal effects in the placebo group compared with risp-
eridone and haloperidol arms in palliative care patients81. Thus, 
current guidelines recommend only pharmacologic treatment 
for select scenarios, such as severe agitation (that is, posing 
harm to self or others or both) and alcohol or benzodiazepine 
withdrawal12,13,78.
Lastly, the lack of delirium guideline implementation may also 
impede delirium prevention and care, especially in the ICU. A 
recent prospective mixed-methods study by Balas et al.18 exam-
ined barriers to guideline dissemination and implementation 
across various ICU settings. Participants reported that (1) knowl-
edge deficits and (2) low confidence with using delirium screening 
tools, particularly as time elapsed after initial training and edu-
cation, served as barriers for delirium guideline implementa-
tion. These findings align with similar studies involving medi-
cal wards, where a staff educational program reduced delirium 
incidence and related complications, including mortality and 
hospital length of stay79. Thus, consistent educational and train-
ing efforts may help prevent delirium and associated deleterious 
outcomes.
Conclusions and future directions
Delirium is a distressing syndrome for older surgical patients 
and their families, and the societal consequences of delirium 
are likely to escalate with a growing older surgical population. 
Advancing our pathophysiologic understanding of delirium 
is likely to inform better screening and diagnostic strategies. 
Neurophysiologic investigation, shaped by a network science 
framework, may improve neurobiologic understanding of delir-
ium mechanisms. Knowledge gaps in relation to pathophysiology 
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may help explain why rigorous, large pharmacologic and non-
pharmacologic trials for delirium prevention have generally 
been disappointing2,20,64 and weigh against current guide-
lines13. Non-pharmacologic, multicomponent interventions are 
not likely to increase the risk of harm and have repeatedly been 
shown to reduce the incidence and impact of delirium31. With 
improving scientific and technological advances and the estab-
lishment of multidisciplinary neuroscience collaborations82,83, 
the time is ripe to improve delirium understanding and 
management.
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